A Rare Case of Gastrointestinal Stromal Tumor of the Abdominal Wall

F. Bobircă, D. Dumitrescu, Lidia Belega-Mursoi, A. Bobircă, Cristina Alexandru, H. Doran, T. Pătraşcu
{"title":"A Rare Case of Gastrointestinal Stromal Tumor of the Abdominal Wall","authors":"F. Bobircă, D. Dumitrescu, Lidia Belega-Mursoi, A. Bobircă, Cristina Alexandru, H. Doran, T. Pătraşcu","doi":"10.31689/rmm.2022.29.4.343","DOIUrl":null,"url":null,"abstract":"Gastrointestinal stromal tumors (GIST) are rarely encountered in medical practice, developing with predilection in people over 40 years old. Their starting point is found in the digestive tract, and can appear anywhere along it. Normally, in the human body cells go through the processes of development, division and then apoptosis. In the case of gastro-intestinal stromal tumors, the cells divide continuously and the process of apoptosis is no longer carried out, forming these tumors, which can be benign or malignant. The essential medical treatment used in the case of gastrointestinal stromal tumors is Imatinib, which has the role of preventing the growth or even regression in size of the tumor in most cases. The specificity marker for GIST is represented by c-KIT protein, and immunohistochemically, the majority of gastrointestinal stromal tumors show positivity for CD34 and c-KIT. There are also extragastro-intestinal stromal tumors, for example located in the liver, duodenum, pancreas, but they are extremely rare, being considered rather as metastases from the primary tumor.","PeriodicalId":380281,"journal":{"name":"Medicina Moderna - Modern Medicine","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Moderna - Modern Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31689/rmm.2022.29.4.343","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Gastrointestinal stromal tumors (GIST) are rarely encountered in medical practice, developing with predilection in people over 40 years old. Their starting point is found in the digestive tract, and can appear anywhere along it. Normally, in the human body cells go through the processes of development, division and then apoptosis. In the case of gastro-intestinal stromal tumors, the cells divide continuously and the process of apoptosis is no longer carried out, forming these tumors, which can be benign or malignant. The essential medical treatment used in the case of gastrointestinal stromal tumors is Imatinib, which has the role of preventing the growth or even regression in size of the tumor in most cases. The specificity marker for GIST is represented by c-KIT protein, and immunohistochemically, the majority of gastrointestinal stromal tumors show positivity for CD34 and c-KIT. There are also extragastro-intestinal stromal tumors, for example located in the liver, duodenum, pancreas, but they are extremely rare, being considered rather as metastases from the primary tumor.
罕见的腹壁胃肠道间质瘤1例
胃肠道间质瘤(GIST)在医疗实践中很少遇到,多发生于40岁以上的人群。它们的起点在消化道,也可以出现在消化道的任何地方。正常情况下,人体细胞经历发育、分裂和凋亡的过程。在胃肠道间质瘤中,细胞不断分裂,不再进行凋亡过程,形成了这些肿瘤,可分为良性或恶性。胃肠道间质瘤的基本药物治疗是伊马替尼,在大多数情况下,伊马替尼具有阻止肿瘤生长甚至缩小的作用。胃肠道间质瘤的特异性标志物是c-KIT蛋白,免疫组织化学显示,大多数胃肠道间质瘤CD34和c-KIT阳性。也有胃外肠间质肿瘤,例如位于肝脏、十二指肠、胰腺,但它们极为罕见,被认为是原发肿瘤的转移瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信